Loading...
HUMAN GLYCOPROTEINS AND DERIVED VARIANTS FROM RECOMBINANT MAMMALIAN CELLLINES
Dittmar, K. E. J. Conradt, H. S. Hauser, H. Hofer, B. Lindenmaier, W.
Dittmar, K. E. J.
Conradt, H. S.
Hauser, H.
Hofer, B.
Lindenmaier, W.
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
1989
Submitted date
2023-11-03
Files
Loading...
PDF
Adobe PDF, 7.36 MB
Other Titles
Abstract
The expression of foreign genes using recombinant DNA technology in various host systems has permitted the production of human proteins of therapeutic interest in high amounts. Manyclinically important human proteins are posttranslationally modified. However, the inability of microbes to perform mammalian-type of posttranslational modifications of proteins is a major shortcoming. Alternative expression systems are insect and mammaliancells. Principle mammalian types of protein modifications are N- and O-glycosylation. Insect cells, fungi and yeasts are unable to perform the same terminal glycosylation reactions on glycoproteins as mammalian cells. Recombinant DNA technology used for the production of pharmaceutically useful polypeptides has mainly been focused on microbial expression systems (bacteria like E. coli, yeast and fungi). The advantage of microbial expression systems is the high amount of expressed protein that can be obtained. The present communication considers aspects of glycoprotein research relevant to the field of biotechnology and protein design. Results are presented that have been obtained by our group during the last four years concerning the expression of the glycoproteins human Interleukin 2 (Il-2) and Interferon-8 (IFN-8) in different mammalian cell lines, the determination of their carbohydrate residues, the effect of site-directed mutagenesis on their carbohydrate attachment sites and the insertion of peptide domains which function as acceptors for carbohydrates.
Citation
Advances in protein design, 145 -156
Journal
DOI
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Book chapter
conference paper
conference paper
Language
en
Description
Series/Report no.
GBF monographs ; Volume 12
ISSN
0930-4320
EISSN
ISBN
0895739534
3527280243
3527280243
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International